Table 2.
Direction of effect | Number of published studies | Total number of participants in the given studies | Specific examples of comparisons made |
---|---|---|---|
Positive | 3 | 4474 |
A. lumbricoides ↔EIB; A. lumbricoides ↔wheeze; T. trichiura ↔SPT (×2) |
Inverse | 6 | 5700 |
Schistosoma spp ↔SPT (×4); A. lumbricoides ↔SPT; Hookworm ↔ wheeze; Hookworm ↔ eczema; T. trichiura ↔eczema; Maternal hookworm in pregnancy ↔ eczema 0‐5 y |
No statistically significant association reported by the whole study | 8 | 7888 | A wide range of combinations |
Both statistically significant and insignificant results reported by the same study | 4 | 6448 | A wide range of combinations |
Positive (anthelmintic treatment) | 1 | 2507 |
Albendazole in pregnancy→eczema in infancy Albendazole in pregnancy→wheeze in infancy Praziquantel in pregnancy →eczema in infancy |
No association (anthelmintic treatment) | 1 | 1188 |
Albendazole in pregnancy→wheeze & SPT at age 9 y Praziquantel in pregnancy→wheeze & SPT at age 9 y Albendazole in early childhood→wheeze & SPT at 9 y |
↔ The two variables tested for association in observational studies
→ The two variables tested for association in clinical trials